Publications

Novel Immunotherapy Tebentafusp Granted Fast Track Designation for Metastatic Uveal Melanoma

May 6, 2019

Source: Targeted Oncology, May 2019 The FDA has granted tebentafusp (IMCgp100) a fast track designation for the treatment of patients with HLA-A*0201-positive previously untreated metastatic uveal melanoma, according to Immunocore…

MRV Newletter Issue 10, May 2019

May 2, 2019

MRV Newsletters, Publications

Please follow this link to download the 10th edition of the MRV newsletter.

Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients

April 29, 2019

Melanoma News, Publications, Scientific Publications

Source: MDLinx, April 2019 Authors evaluated the survival outcomes in candidates who underwent retreatment of recurrent cutaneous melanoma of the head and neck between January 1, 2000, and December 31,…

Contrast-enhanced ultrasound with perflubutane for sentinel lymph node mapping in cutaneous melanoma: A pilot study

April 26, 2019

Melanoma News, Publications, Scientific Publications

Source: MDLinx, April 2019 In this single-arm pilot study in a swine animal model, authors estimated the accessibility of contrast-enhanced ultrasound (CEUS) to recognize the sentinel lymph node (SLN) associated…

Publications

Novel Immunotherapy Tebentafusp Granted Fast Track Designation for Metastatic Uveal Melanoma

MRV Newletter Issue 10, May 2019

Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients

Contrast-enhanced ultrasound with perflubutane for sentinel lymph node mapping in cutaneous melanoma: A pilot study

MRV News

Melanoma News

Archive

Our Partners

Melanoma Research Victoria

Quick Links